Consequences of proceeding with surgery after resuscitation from intra-operative anaphylaxis

Anaesthesia

Volumn 73, Issue 1, 2018, Pages 32-39

  Sadleir, P H M ^a,b,c   Clarke, R C ^a,c   Bozic, B ^a   Platt, P R ^a,c  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Anaesthetic Allergy Referral Centre of Western Australia   (Australia)

Author keywords

allergy; anaesthesia; anaphylaxis; complications; risk; surgery

Indexed keywords

EPINEPHRINE; METHYLENE BLUE; MIDAZOLAM; PROTAMINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BRAIN DISEASE; BRONCHOSPASM; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; LUNG VENTILATION; MAJOR CLINICAL STUDY; MIDDLE AGED; PATIENT REFERRAL; PROSPECTIVE STUDY; RESUSCITATION; RETROSPECTIVE STUDY; TAKOTSUBO CARDIOMYOPATHY; TIME TO TREATMENT; TOTAL QUALITY MANAGEMENT; VENTILATOR ASSOCIATED PNEUMONIA; WESTERN AUSTRALIA; ACUTE DISEASE; AGED; CASE CONTROL STUDY; CHEMICALLY INDUCED; COMPLICATION; DRUG HYPERSENSITIVITY; FEMALE; MALE; PEROPERATIVE COMPLICATION; SURGERY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANAPHYLAXIS; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; RESUSCITATION; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; WESTERN AUSTRALIA;

EID: 85032815712     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.14106     Document Type: Article

References (10)

1. Gibbs NM, Sadleir PHM, Clarke RC, Platt PR. Survival from perioperative anaphylaxis in Western Australia 2000-2009. British Journal of Anaesthesia 2013; 111: 589–93.
2. Reitter M, Petitpain N, Latarche C, et al. Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis. European Journal of Allergy and Clinical Immunology 2014; 69: 954–9.
3. Harper NJN, Dixon T, Dugue P, et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009; 64: 199–211.
4. Kroigaard M, Garvey LH, Gillberg L, et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiologica Scandinavica 2007; 51: 655–70.
5. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. Journal of Allergy and Clinical Immunology 2010; 126: 477–80.
6. Australian and New Zealand Anaesthetic Allergy Group. 2013. ANZAAG Anaphylaxis Management Guidelines. http://www.anzaag.com/Mgmt%20Resources.aspx (accessed 10/06/2015).
7. Platt PR, Clarke RC, Johnson GH, Sadleir PHM. Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A case-control study. Anaesthesia 2015; 70: 1264–7.
8. Selwyn MR. Principles of experimental design for the life sciences. Florida, USA: CRC Press, 1996.
9. Sadleir PHM, Clarke RC, Bunning DL, Platt PR. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. British Journal of Anaesthesia 2013; 110: 981–7.
10. Mertes PM, Laxenaire MC, Alla F. Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 2003; 99: 536–45.